CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
主要な著者: | Guang Wang, Juan Fu, Mulin Liu, Qin Zheng |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Public Library of Science (PLoS)
2024-01-01
|
シリーズ: | PLoS ONE |
オンライン・アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI |
類似資料
-
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
著者:: Guang Wang, 等
出版事項: (2024-01-01) -
The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
著者:: Yonghui Wang, 等
出版事項: (2020-01-01) -
The Role of CXC Chemokines in Cardiovascular Diseases
著者:: Xiyi Lu, 等
出版事項: (2022-05-01) -
Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
著者:: Tesfaye Wolde, 等
出版事項: (2024-02-01) -
FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
著者:: N. V. Kipich, 等
出版事項: (2014-07-01)